美国血液技术 (HAE.N)

+ 收藏

现金流量表(美国血液技术)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2025年三季报2025年中报2025年一季报2024年年报2024年三季报2024年中报2024年一季报
起始日期 2025-03-302025-03-302025-03-302024-03-312024-03-312024-03-312024-03-31
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
报表年结日 0328032803280329032903290329
原始币种 美元美元美元美元美元美元美元
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
经营活动产生的现金流量:
 净利润(元) 会员可见会员可见会员可见会员可见109,698,000.0072,204,000.0038,373,000.00
 折旧及摊销(元) 会员可见会员可见会员可见会员可见99,697,000.0067,331,000.0034,375,000.00
 基于股票的补偿费(元) 会员可见会员可见会员可见会员可见22,699,000.0014,485,000.007,628,000.00
 减值及拨备(元) 会员可见会员可见-会员可见3,680,000.008,465,000.003,602,000.00
 递延所得税(元) 会员可见会员可见会员可见会员可见-8,593,000.00-6,176,000.00-
 资产处置损益(元) 会员可见会员可见会员可见会员可见-14,572,000.00-14,412,000.00-14,291,000.00
 投资损益(元) ---会员可见-12,600,000.00-12,600,000.00-12,600,000.00
 重估盈余(元) ---会员可见---
 经营业务调整其他项目(元) 会员可见会员可见会员可见会员可见8,114,000.004,523,000.00-1,927,000.00
 存货的减少(增加)(元) 会员可见会员可见会员可见会员可见-65,629,000.00-53,082,000.00-39,830,000.00
 应收账款及票据减少(增加)(元) 会员可见会员可见会员可见会员可见-3,379,000.00-1,608,000.007,970,000.00
 应付账款及票据增加(减少)(元) 会员可见会员可见会员可见会员可见-36,816,000.00-40,125,000.00-44,105,000.00
 应付税项(元) 会员可见会员可见会员可见会员可见-2,638,000.00-3,713,000.003,223,000.00
 经营业务其他项目(元) 会员可见会员可见会员可见会员可见-34,493,000.00-13,890,000.00-9,839,000.00
 经营活动产生的现金流量净额(元) 会员可见会员可见会员可见会员可见65,168,000.0021,402,000.00-27,421,000.00
投资活动产生的现金流量:
 处置固定资产收到的现金(元) 会员可见会员可见会员可见会员可见20,802,000.0020,551,000.0020,362,000.00
 投资支付现金(元) 会员可见会员可见会员可见会员可见-23,635,000.00-15,089,000.00-5,656,000.00
 收购附属公司(元) ---会员可见-150,906,000.00-150,906,000.00-149,151,000.00
 投资业务其他项目(元) 会员可见会员可见会员可见会员可见-26,196,000.00-17,120,000.00-4,752,000.00
 投资活动产生的现金流量净额(元) 会员可见会员可见会员可见会员可见-179,935,000.00-162,564,000.00-139,197,000.00
融资活动产生的现金流量:
 新增借款(元) ---会员可见200,000,000.00200,000,000.00200,000,000.00
 偿还借款(元) 会员可见会员可见-会员可见-3,125,000.00-1,563,000.00-1,563,000.00
 回购股份(元) 会员可见会员可见-会员可见-75,000,000.00-75,000,000.00-
 发行债券(元) ---会员可见700,000,000.00700,000,000.00700,000,000.00
 赎回债券(元) ---会员可见-185,500,000.00-185,500,000.00-185,500,000.00
 行使股票期权所得(元) 会员可见会员可见会员可见-8,193,000.004,653,000.004,402,000.00
 贷款收益(元) --会员可见会员可见---
 发行费用相关(元) ---会员可见-23,135,000.00-23,135,000.00-23,135,000.00
 其他筹资活动产生的现金流量净额(元) 会员可见会员可见会员可见会员可见-222,000.00-73,000.00-62,000.00
 筹资业务其他项目(元) 会员可见会员可见会员可见会员可见-360,943,000.00-360,494,000.00-360,450,000.00
 融资活动产生的现金流量净额(元) 会员可见会员可见会员可见会员可见260,268,000.00258,888,000.00333,692,000.00
汇率变动影响(元) 会员可见会员可见会员可见会员可见-3,455,000.002,757,000.00-1,445,000.00
现金及现金等价物期初余额(元) 会员可见会员可见会员可见会员可见178,800,000.00178,800,000.00178,800,000.00
现金及现金等价物增加(减少)额(元) 会员可见会员可见会员可见会员可见142,046,000.00120,483,000.00165,629,000.00
现金及现金等价物期末余额(元) 会员可见会员可见会员可见会员可见320,846,000.00299,283,000.00344,429,000.00
利息支付(元) ---会员可见---
所得税支付(元) ---会员可见---
公告日期 2026-02-052025-11-062025-08-072025-05-212025-02-062024-11-072024-08-08
会计准则 美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则
审计意见
核数师

前瞻产业研究院